263 related articles for article (PubMed ID: 34120149)
1. Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial.
Grodin EN; Bujarski S; Towns B; Burnette E; Nieto S; Lim A; Lin J; Miotto K; Gillis A; Irwin MR; Evans C; Ray LA
Transl Psychiatry; 2021 Jun; 11(1):355. PubMed ID: 34120149
[TBL] [Abstract][Full Text] [Related]
2. Ibudilast attenuates alcohol cue-elicited frontostriatal functional connectivity in alcohol use disorder.
Burnette EM; Ray LA; Irwin MR; Grodin EN
Alcohol Clin Exp Res; 2021 Oct; 45(10):2017-2028. PubMed ID: 34585396
[TBL] [Abstract][Full Text] [Related]
3. The effect of neuroimmune modulation on subjective response to alcohol in the natural environment.
Meredith LR; Grodin EN; Montoya AK; Miranda R; Squeglia LM; Towns B; Evans C; Ray LA
Alcohol Clin Exp Res; 2022 May; 46(5):876-890. PubMed ID: 35362101
[TBL] [Abstract][Full Text] [Related]
4. Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial.
Burnette EM; Baskerville WA; Grodin EN; Ray LA
Trials; 2020 Sep; 21(1):779. PubMed ID: 32912290
[TBL] [Abstract][Full Text] [Related]
5. Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study.
Grodin EN; Meredith LR; Burnette EM; Miotto K; Irwin MR; Ray LA
Am J Drug Alcohol Abuse; 2023 May; 49(3):333-344. PubMed ID: 36282988
[No Abstract] [Full Text] [Related]
6. Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder.
Nieto SJ; Grodin EN; Burnette EM; Cahill CM; Ray LA
Alcohol Alcohol; 2022 Nov; 57(6):727-733. PubMed ID: 35788255
[TBL] [Abstract][Full Text] [Related]
7. Ibudilast moderates the effect of mood on alcohol craving during stress exposure.
Meredith LR; Green R; Grodin EN; Chorpita M; Miotto K; Ray LA
Exp Clin Psychopharmacol; 2022 Oct; 30(5):620-631. PubMed ID: 36102596
[TBL] [Abstract][Full Text] [Related]
8. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.
Ray LA; Bujarski S; Shoptaw S; Roche DJ; Heinzerling K; Miotto K
Neuropsychopharmacology; 2017 Aug; 42(9):1776-1788. PubMed ID: 28091532
[TBL] [Abstract][Full Text] [Related]
9. Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial.
Wetherill RR; Spilka N; Jagannathan K; Morris P; Romer D; Pond T; Lynch KG; Franklin TR; Kranzler HR
Neuropsychopharmacology; 2021 Jul; 46(8):1414-1420. PubMed ID: 33558678
[TBL] [Abstract][Full Text] [Related]
10. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
Schacht JP; Anton RF; Randall PK; Li X; Henderson S; Myrick H
Psychopharmacology (Berl); 2014 Sep; 231(18):3799-807. PubMed ID: 24647921
[TBL] [Abstract][Full Text] [Related]
11. Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial.
Grodin EN; Nieto SJ; Meredith LR; Burnette E; O'Neill J; Alger J; London ED; Miotto K; Evans CJ; Irwin MR; Ray LA
Addict Biol; 2022 Jul; 27(4):e13182. PubMed ID: 35754106
[TBL] [Abstract][Full Text] [Related]
12. Alcohol Cue Processing in Co-Occurring Bipolar Disorder and Alcohol Use Disorder.
Mellick WH; Tolliver BK; Brenner HM; Anton RF; Prisciandaro JJ
JAMA Psychiatry; 2023 Nov; 80(11):1150-1159. PubMed ID: 37556131
[TBL] [Abstract][Full Text] [Related]
13. Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder.
Karl D; Bumb JM; Bach P; Dinter C; Koopmann A; Hermann D; Mann K; Kiefer F; Vollstädt-Klein S
Psychopharmacology (Berl); 2021 Aug; 238(8):2179-2189. PubMed ID: 33846866
[TBL] [Abstract][Full Text] [Related]
14. Neural correlates of the addictions neuroclinical assessment (ANA) incentive salience factor among individuals with alcohol use disorder.
Nieto SJ; Grodin EN; Ray LA
Behav Brain Res; 2024 Apr; 464():114926. PubMed ID: 38431152
[TBL] [Abstract][Full Text] [Related]
15. Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
Miranda R; O'Malley SS; Treloar Padovano H; Wu R; Falk DE; Ryan ML; Fertig JB; Chun TH; Muvvala SB; Litten RZ
Alcohol Clin Exp Res; 2020 Jul; 44(7):1431-1443. PubMed ID: 32363592
[TBL] [Abstract][Full Text] [Related]
16. Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers.
Grodin EN; Burnette EM; Green R; Lim AC; Miotto K; Ray LA
Drug Alcohol Depend; 2021 Aug; 225():108825. PubMed ID: 34175784
[TBL] [Abstract][Full Text] [Related]
17. Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals.
Logge WB; Morris RW; Baillie AJ; Haber PS; Morley KC
Psychopharmacology (Berl); 2021 May; 238(5):1291-1302. PubMed ID: 30788529
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.
Schacht JP; Randall PK; Latham PK; Voronin KE; Book SW; Myrick H; Anton RF
Neuropsychopharmacology; 2017 Dec; 42(13):2640-2653. PubMed ID: 28409564
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial.
Schacht JP; Voronin KE; Randall PK; Anton RF
Neuropsychopharmacology; 2018 May; 43(6):1247-1256. PubMed ID: 29362512
[TBL] [Abstract][Full Text] [Related]
20. Neural Correlates of Stress and Alcohol Cue-Induced Alcohol Craving and of Future Heavy Drinking: Evidence of Sex Differences.
Radoman M; Fogelman N; Lacadie C; Seo D; Sinha R
Am J Psychiatry; 2024 May; 181(5):412-422. PubMed ID: 38706332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
